Comparative effectiveness of glucagon‐like peptide‐1 receptor agonists for the management of obesity in adults without diabetes: A network meta‐analysis of randomized clinical trials-Reference-Cited by-同舟云学术

Comparative effectiveness of glucagon‐like peptide‐1 receptor agonists for the management of obesity in adults without diabetes: A network meta‐analysis of randomized clinical trials

Published:2022-12-29 Issue:3 Volume:24 Page:
ISSN:1467-7881
Container-title:Obesity Reviews
language:en
Short-container-title:Obesity Reviews

Author:

Alkhezi Omar S.¹²^ORCID,Alahmed Abdullah A.¹³^ORCID,Alfayez Osamah M.³^ORCID,Alzuman Osama A.⁴,Almutairi Abdulaali R.⁵^ORCID,Almohammed Omar A.⁴⁶^ORCID

Affiliation:

1. Department of Pharmacy Services Brigham and Women's Hospital Boston Massachusetts USA

2. Department of Pharmacy Practice, Unaizah College of Pharmacy Qassim University Qassim Saudi Arabia

3. Department of Pharmacy Practice, College of Pharmacy Qassim University Qassim Saudi Arabia

4. Department of Clinical Pharmacy, College of Pharmacy King Saud University Riyadh Saudi Arabia

5. Drug Sector Saudi Food and Drug Authority Riyadh Saudi Arabia

6. Pharmacoeconomics Research Unit, College of Pharmacy King Saud University Riyadh Saudi Arabia

Funder

King Saud University

Publisher

Wiley

Subject

Public Health, Environmental and Occupational Health,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/obr.13543

Reference39 articles.

1. World Health Organization.Obesity and overweight.https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Published 2021. Updated 9 June 2021. Accessed 4 July 2022.

2. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults

3. Assessment and Lifestyle Management of Patients With Obesity

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stratified analysis of the association between anti-obesity medications and digestive adverse events: a real-world study based on the FDA adverse event reporting system database;BMC Pharmacology and Toxicology;2024-09-12

2. Anti‐Obesity Medication in the Management of Children and Adolescents With Obesity: Recent Developments and Research Gaps;Clinical Endocrinology;2024-09-11

3. Polypeptides-Based Nanocarriers in Tumor Therapy;Pharmaceutics;2024-09-10

4. Effects of Once-Weekly Subcutaneous Retatrutide on Weight and Metabolic Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials;Metabolism Open;2024-09

5. Liraglutide’s Effect on Weight Management in Subjects With Pre-diabetes: A Systematic Review & Meta-Analysis;Endocrine Practice;2024-08